---
schema_version: "secwatch.filing_event.v1"
accession: "0000356037-24-000023"
form_type: "8-K"
ticker: "CSPI"
cik: "0000356037"
company_name: "CSP INC /MA/"
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T14:22:51.430580+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CSP Inc. Q2 net income surges to $1.6M; services revenue up 23%, gross margin expands to 47%

## Summary
- Net income $1.6M ($0.16 diluted EPS) vs $0.3M ($0.03) a year ago, nearly five-fold increase.
- Revenue $13.7M, up slightly from $13.3M; services revenue grew 23% to $5.2M.
- Gross margin improved to 47% from 38% on higher-margin services and AZT sale.
- Board declared $0.03 quarterly dividend, payable June 12 to holders of record May 24.
- Global pharmaceutical company signed multi-million dollar AZT PROTECT contract; AZT launch expanded to mid-market.

## SEC filing metadata
- accession: 0000356037-24-000023
- form_type: 8-K
- ticker: CSPI
- cik: 0000356037
- company_name: CSP INC /MA/
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/356037/000035603724000023/0000356037-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/356037/000035603724000023/cspi-20240508x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000356037-24-000023
- JSON: https://secwatch.observer/filing/0000356037-24-000023.json
- Plain text: https://secwatch.observer/filing/0000356037-24-000023.txt

## Key facts
- Earnings Releases
  CSP INC /MA/ reported fiscal second quarter ended March 31, 2024 results: revenue $13.7 million, net income $1.6 million, EPS $0.16 per diluted common share.
  - Period: fiscal second quarter ended March 31, 2024
  - Revenue: $13.7 million
  - Net income: $1.6 million
  - EPS: $0.16 per diluted common share
  - Result: reported results
  source text: Revenue for the fiscal second quarter ended March 31, 2024, was up slightly to $13.7 million compared to revenue of $13.3 million for the fiscal second quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/356037/000035603724000023/0000356037-24-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.